Aaron Carroll wears many hats: He's a pediatric physician, the chief health officer for Indiana University, a popular New York Times contributor, and the editor-in-chief of The Incidental Economist. Here's what he recently told us about the "dirty secrets" of medicine, the risks (and opportunities) for clinicians engaging on social media, and the best ways for clinicians to fight coronavirus myths in their practices.
As variants of SARS-CoV-2—the coronavirus that causes Covid-19—continue to spread around the world, scientists have hypothesized three key ways the virus could evolve in the future, Emily Anthes reports for the New York Times.
Although CDC and various health experts recommend vaccination regardless of prior Covid-19 infection, some say the combined immunity from infection and an initial vaccination may be protective enough that booster doses are not needed among that population.
Hospitals and surgical centers are increasingly asking that patients pay for nonemergency services in advance—but patient advocates argue these advance payments make it more challenging for people to pay for care, Stephanie Goldberg reports for Modern Healthcare. Advisory Board expert Lauren E. Robinson discusses three ways for organizations to ensure their point of service collections policy is not an Achilles’ heel.
FDA on Tuesday released data on potential Covid-19 booster shots for Moderna and Johnson & Johnson vaccine recipients, but the agency's staff chose not to take a position on whether those boosters were necessary ahead of the meeting of an independent advisory panel.
Most Americans want the federal government to negotiate lower drug prices both for Medicare beneficiaries and those covered by private health plans—even after hearing arguments against the policy, according to a recent Kaiser Family Foundation poll. Explore the poll's findings on our interactive chart.